Evofem Biosciences enrolls first patient in Phase 2b/3 Clinical Trial assessing Amphora’s ability to foil UCG in women Read more
ProMIS Neurosciences claimed further results of previously claimed Preclinical program for Alzheimer’s Disease Read more
CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH Read more